[Therapeutically induced immunodeficiency]
- PMID: 1724857
[Therapeutically induced immunodeficiency]
Abstract
Therapeutically induced immundefects principally can be the result of pathophysiological influences on autoimmune diseases by immunomodulation on the one hand or loss of resistance against bacteria, fungi or viruses as a consequence of immunomodulation on the other hand. Further complications such as increasing incidence of neoplasms after long-term therapy, hypersensitivity reactions, especially damage of bone marrow, can be recognised after application of many different drugs. The immunesuppressive drugs are discussed in detail.
Similar articles
-
[Cytostatic agents and defense].Schweiz Med Wochenschr. 1986 Aug 23;116(34):1145-50. Schweiz Med Wochenschr. 1986. PMID: 3532312 Review. German.
-
[Neurogenic immunodeficiency].Vestn Akad Med Nauk SSSR. 1988;(11):85-92. Vestn Akad Med Nauk SSSR. 1988. PMID: 2907218 Review. Russian. No abstract available.
-
[Secondary immunodeficiency diseases].Nihon Rinsho. 1993 Jan;51 Suppl:622-9. Nihon Rinsho. 1993. PMID: 8459595 Japanese. No abstract available.
-
Historical and current perspectives on bone marrow transplantation for prevention and treatment of immunodeficiencies and autoimmunities.Biol Blood Marrow Transplant. 2001;7(3):123-35. doi: 10.1053/bbmt.2001.v7.pm11302546. Biol Blood Marrow Transplant. 2001. PMID: 11302546
-
Current perspectives on primary immunodeficiency diseases.Clin Dev Immunol. 2006 Jun-Dec;13(2-4):223-59. doi: 10.1080/17402520600800705. Clin Dev Immunol. 2006. PMID: 17162365 Free PMC article. Review.